Recalls / Active ingredient / Clindamycin Phosphate

Clindamycin Phosphate

7 FDA drug recalls involving the active ingredient “Clindamycin Phosphate”.

Date	Class	Product	Firm
2025-11-26	Class III	Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Tar	SUN PHARMACEUTICAL INDUSTRIES INC
2024-02-12	Class II	CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral, Oph	MCKESSON CORPORATION
2019-03-15	Class III	Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by P	Pfizer Inc.
2019-03-15	Class III	Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Ph	Pfizer Inc.
2019-03-15	Class III	Cleocin Phosphate, clindamycin injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vial, Rx only, Distributed by Ph	Pfizer Inc.
2016-12-28	Class II	Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g tubes, Rx Only, Manufactured by Perrigo, Yeruham	L. Perrigo Company
2013-06-04	Class II	Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150	Pharmacia & Upjohn LLC